Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

European Psychiatric Association guidance on treatment of cognitive impairment in schizophrenia
Antonio Vita, Wolfgang Gäebel, Armida Mucci, et al.
European Psychiatry (2022) Vol. 65, Iss. 1
Open Access | Times Cited: 88

Showing 1-25 of 88 citing articles:

Evidence-based psychosocial interventions in schizophrenia: a critical review
Sergio Barlati, Gabriele Nibbio, Antonio Vita
Current Opinion in Psychiatry (2024) Vol. 37, Iss. 3, pp. 131-139
Open Access | Times Cited: 23
Durability of Effects of Cognitive Remediation on Cognition and Psychosocial Functioning in Schizophrenia: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
Antonio Vita, Sergio Barlati, Anna Ceraso, et al.
American Journal of Psychiatry (2024) Vol. 181, Iss. 6, pp. 520-531
Closed Access | Times Cited: 20
Impact of Physical Exercise Alone or in Combination with Cognitive Remediation on Cognitive Functions in People with Schizophrenia: A Qualitative Critical Review
Giacomo Deste, Daniele Corbo, Gabriele Nibbio, et al.
Brain Sciences (2023) Vol. 13, Iss. 2, pp. 320-320
Open Access | Times Cited: 24
Pharmacological Treatment of Cognitive Impairment Associated With Schizophrenia: State of the Art and Future Perspectives
Antonio Vita, Gabriele Nibbio, Sergio Barlati
Schizophrenia Bulletin Open (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 12
Negative symptoms and social cognition as mediators of the relationship between neurocognition and functional outcome in schizophrenia
Giulia Maria Giordano, Pasquale Pezzella, Armida Mucci, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 9
Antipsychotic Drugs and Cognitive Function
Lena Feber, Natalie Peter, Virginia Chiocchia, et al.
JAMA Psychiatry (2024)
Closed Access | Times Cited: 9
Clinical practice guidelines for assessment and management of cognitive impairment in schizophrenia
Sandeep Grover, Debadatta Mohapatra, Sridhar Vaitheswaran, et al.
Indian Journal of Psychiatry (2025) Vol. 67, Iss. 1, pp. 65-83
Open Access | Times Cited: 1
Antipsychotic Drugs: A Concise Review of History, Classification, Indications, Mechanism, Efficacy, Side Effects, Dosing, and Clinical Application
Stefan Leucht, Josef Priller, John M. Davis
American Journal of Psychiatry (2024) Vol. 181, Iss. 10, pp. 865-878
Closed Access | Times Cited: 8
Conceptualization and characterization of “primary” and “secondary” cognitive impairment in schizophrenia
Antonio Vita, Gabriele Nibbio, Sergio Barlati
Psychiatry Research (2024) Vol. 340, pp. 116126-116126
Open Access | Times Cited: 6
Neuroinflammation and kynurenines in schizophrenia: Impact on cognition depending on cognitive functioning and modulatory properties in relation to cognitive remediation and aerobic exercise
Jacopo Sapienza, Giulia Agostoni, Stefano Comai, et al.
Schizophrenia Research Cognition (2024) Vol. 38, pp. 100328-100328
Open Access | Times Cited: 6
Life engagement in people living with schizophrenia: predictors and correlates of patient life engagement in a large sample of people living in the community
Antonio Vita, Sergio Barlati, Giacomo Deste, et al.
Psychological Medicine (2023) Vol. 53, Iss. 16, pp. 7943-7952
Open Access | Times Cited: 15
Application of cognitive remediation in the world: new experiences from two schizophrenia rehabilitation centers in Togo and Benin
Giacomo Deste, Mawuko Kakli, Sergio Barlati, et al.
Social Psychiatry and Psychiatric Epidemiology (2024) Vol. 59, Iss. 10, pp. 1775-1783
Open Access | Times Cited: 5
Improving depressive symptoms in patients with schizophrenia using bilateral bipolar-nonbalanced prefrontal tDCS: Results from a double-blind sham-controlled trial
Jacopo Lisoni, Gabriele Nibbio, Giulia Baldacci, et al.
Journal of Affective Disorders (2024) Vol. 349, pp. 165-175
Closed Access | Times Cited: 5
Implementation of Cognitive Health Services in Large Systems of Care: Highlights From Coordinated Specialty Care for First Episode Psychosis
Alice M. Saperstein, Iruma Bello, Ilana Nossel, et al.
Schizophrenia Bulletin (2024) Vol. 50, Iss. 5, pp. 984-992
Closed Access | Times Cited: 5
The Impact of Prolonged Duration of Untreated Illness on Clinical Correlates in Chronic Schizophrenia: Exploring the Relationship With Suicide Risk
K. Zhang, C. Wang, Lei Gou, et al.
Psychiatry Investigation (2024) Vol. 21, Iss. 4, pp. 422-432
Open Access | Times Cited: 4
Treatment of Cognitive Impairment Associated with Schizophrenia Spectrum Disorders: New Evidence, Challenges, and Future Perspectives
Irene Calzavara‐Pinton, Gabriele Nibbio, Sergio Barlati, et al.
Brain Sciences (2024) Vol. 14, Iss. 8, pp. 791-791
Open Access | Times Cited: 4
Investigating the causal pathways among psychopathological variables, cognitive impairment, and real-life functioning in people with schizophrenia
Luigi Giuliani, Francesco Sanmarchi, Armida Mucci, et al.
Schizophrenia (2025) Vol. 11, Iss. 1
Open Access
International Perspective on Social Cognition in Schizophrenia: Current Stage and the Next Steps
Sílvia Corbera, Matthew M. Kurtz, Amélie M. Achim, et al.
European Psychiatry (2025), pp. 1-72
Open Access
Risperidone In Situ Microparticles: A Review in Schizophrenia
Yahiya Y. Syed
Drugs (2025)
Closed Access
Social cognitive training among individuals with schizophrenia: Identifying responders to treatment
Anja Vaskinn, André Løvgren, Ole A. Andreassen, et al.
Schizophrenia Research Cognition (2025) Vol. 40, pp. 100350-100350
Closed Access
Investigating the association of the plasma lipidomic profile with cognitive performance and genetic risk in the PsyCourse study
Mojtaba Oraki Kohshour, Sergi Papiol, Anna Tkachev, et al.
Translational Psychiatry (2025) Vol. 15, Iss. 1
Open Access
Current limitations in technology-based cognitive assessment for severe mental illnesses: a focus on feasibility, reliability, and ecological validity
Edoardo Caporusso, Antonio Melillo, Andrea Perrottelli, et al.
Frontiers in Behavioral Neuroscience (2025) Vol. 19
Open Access
Effect of the Part-to-Whole Program on Functional Remission in Schizophrenia: A Randomized Controlled Community Mental Health Study
Fatma Nevin Şişman, Seda Dulcek, Fikret Erdogan, et al.
Journal of Psychosocial Nursing and Mental Health Services (2025), pp. 1-9
Closed Access
Correlations between Negative Symptoms and Cognitive Deficits in Individuals at First Psychotic Episode or at High Risk of Psychosis: A Systematic Review
Antonio Melillo, Edoardo Caporusso, Giulia Maria Giordano, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 22, pp. 7095-7095
Open Access | Times Cited: 10
Changes in BDNF methylation patterns after cognitive remediation therapy in schizophrenia: A randomized and controlled trial
Rafael Penadés, Carmen Almodóvar-Payá, Clemente García-Rizo, et al.
Journal of Psychiatric Research (2024) Vol. 173, pp. 166-174
Closed Access | Times Cited: 3
Page 1 - Next Page

Scroll to top